Abbott Laboratories logo

Abbott Laboratories

TickerABTVenueUSSectorHealthcarePrimary listingBeta0.59
$104.9+0.19%
FinScore60

Abbott Laboratories is a United States-based company in the Healthcare sector with a market capitalisation of $181.5B. Its FinScore is 60/100; its highest-scoring layer is Quality (76) and its lowest is Value (42). The shares trade at 33.5x trailing earnings and are down 16% year to date.

Market cap
$181.5B
P/E (TTM)
33.5x
Dividend yield (TTM)
2.36%
ROE
10.5%

Share price performance

Loading chart…

About Abbott Laboratories

www.abbott.com

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Profile
Sector
Healthcare
Industry
Medical - Devices
HQ
United States
Fiscal year-end
December
Trading currency
USD
Reporting currency
USD
Fundamentals updated
yesterday
Market
Market cap
$181.5B
Shares outstanding
1.7B
P/E (TTM)
33.5x
Dividend yield (TTM)
2.36%
Beta (issuer)
0.58
Revenue (latest FY)
$44.3B

Revenue breakdown

FY 2025$44.3B
  • Medical Devices
    48.3%$21.4B
  • Diagnostic Products
    20.2%$8.9B
  • Nutritional Products
    19.1%$8.5B
  • Established Pharmaceutical Products
    12.5%$5.5B

FinScore

As of 2026-10-19
Overall60
Quality76
Growth45
Value42
Momentum68
Relative Strength71

Snapshot

Ownership

As of 2026-06-30
Institutional
82.2%
Insider
0.4%
Free float
99.4%
Top-5 institutional holders
26.7%
Shares outstanding
1.7B
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Abbott Laboratories is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Abbott Laboratories is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Abbott Laboratories is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Abbott Laboratories is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Abbott Laboratories is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Abbott Laboratories is available to Finryse members. The Overview stays open to everyone; creating an account is free.